TNPO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.264600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.792800E-01
Normal-vs-Stage2
9.214200E-01
Normal-vs-Stage3
2.599900E-02
Normal-vs-Stage4
3.674200E-01
Stage1-vs-Stage2
6.461800E-01
Stage1-vs-Stage3
1.584120E-02
Stage1-vs-Stage4
3.329400E-01
Stage2-vs-Stage3
2.44249999999946E-05
Stage2-vs-Stage4
1.363610E-01
Stage3-vs-Stage4
6.155700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.918200E-01
Normal-vs-AfricanAmerican
5.275000E-01
Normal-vs-Asian
3.646600E-01
Caucasian-vs-AfricanAmerican
3.230600E-01
Caucasian-vs-Asian
1.294240E-01
AfricanAmerican-vs-Asian
6.994400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.219800E-01
Normal-vs-Female
9.359400E-01
Male-vs-Female
9.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.585400E-01
Normal-vs-Age(41-60Yrs)
6.874400E-01
Normal-vs-Age(61-80Yrs)
7.339400E-01
Normal-vs-Age(81-100Yrs)
4.921000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.046000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.160800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.315000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.136300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.504100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.085000E-01
Normal-vs-Daily Drinker
5.050600E-01
Normal-vs-Weekly Drinker
4.956800E-01
Normal-vs-Occasional Drinker
7.477600E-01
Normal-vs-Social Drinker
6.854000E-01
Non Drinker-vs-Daily Drinker
6.988200E-01
Non Drinker-vs-Weekly Drinker
8.246600E-01
Non Drinker-vs-Occasional Drinker
3.630000E-02
Non Drinker-vs-Social Drinker
3.641800E-02
Daily Drinker-vs-Weekly Drinker
9.217000E-01
Daily Drinker-vs-Occasional Drinker
7.785600E-02
Daily Drinker-vs-Social Drinker
6.202000E-02
Weekly Drinker-vs-Occasional Drinker
1.135200E-01
Weekly Drinker-vs-Social Drinker
9.283600E-02
Occasional Drinker-vs-Social Drinker
8.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.990380E-01
Normal-vs-Grade 2
8.172100E-02
Normal-vs-Grade 3
4.247900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.870400E-01
Grade 1-vs-Grade 3
8.331600E-01
Grade 1-vs-Grade 4
1.990380E-01
Grade 2-vs-Grade 3
5.738400E-01
Grade 2-vs-Grade 4
8.172100E-02
Grade 3-vs-Grade 4
4.247900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.953800E-01
Normal-vs-NonDiabetic
7.774800E-01
Diabetic-vs-NonDiabetic
7.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.682600E-01
Normal-vs-NoPancreatitis
8.524400E-01
Pancreatitis-vs-NoPancreatitis
2.534400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.552200E-01
Normal-vs-N1
9.291600E-01
N0-vs-N1
9.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.395600E-01
Normal-vs-TP53-NonMutant
8.184400E-01
TP53-Mutant-vs-TP53-NonMutant
9.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
